InvestorsHub Logo
Followers 104
Posts 522
Boards Moderated 0
Alias Born 06/13/2018

Re: drugrunner post# 274798

Thursday, 04/02/2020 6:36:24 PM

Thursday, April 02, 2020 6:36:24 PM

Post# of 700589
I agree with you and would add that something I haven't seen mentioned by anyone is that the non compete restriction would also apply when he moved from Merck to NWBO. So is not just one case, but two cases where it is strange that he stops working from one company and immediately starts with other. That is other reason why I also think he was helping with the SAP and NWBO DD and his work finished.

Finally, an offer he couldn't refuse could be a consequence of a clause that prohibits NWBO to offer him a definitive position post-assignment as part of the agreement / NDA signed by Merck and NWBO to bring Duffy temporarily. With this, DI is not lying, just saying the reason why he went back to Merck without giving hints of an agreement (actually, if DI would have given hints of some type of agreement, the company would be legally liable). On the other hand, if it was that Duffy just quit because the trial is failed or something like that, DI would make the company legally liable and I don't think they will take that risk with what happened in the past.


PD. Sorry if my English is not so Good. Not my native language.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News